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INTRODUCTION 
 
Age-related macular degeneration (AMD), the leading 
cause of blindness in the world, is under intensive 
investigation but its pathogenesis remains poorly 
understood. According to the clinical signs, it is usually 
defined two forms of this disease: atrophic (80-90%) 
and exudative (about 10% of cases). Atrophic (or dry) 
form is characterized by progressive degeneration of 
retinal pigment epithelium (RPE) and photoreceptor 
cells. Exudative (or wet) form is characterized by 
edema, spot bleeding, inflammation and choroidal neo-
vascularization (CNV) which is a cause of ~90% of 
blindness from AMD. The RPE is a polarized mono-
layer of  epithelial  cells that  separates  the neural retina 
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and the choroidal blood supply and forms a highly 
selective barrier fundamentally important for 
maintaining the health and integrity of the photo-
receptors [1,2]. For several reasons, degeneration of 
RPE can create prerequisites for disease development 
and cause an alteration of choroid vessels [3,4]. RPE 
cells secrete many regulatory factors, including VEGF 
and PEDF [1,5-8].  It is well established that vascular 
endothelial growth factor A (VEGF-A), the member of 
a large family of growth factors, is a key regulator of 
physiological and pathological angiogenesis and vascu-
lar permeability [9,10].  
 
Experimental and clinical studies showed that VEGF is 
increased in retinal pigment epithelium (RPE)/choroid 
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Abstract: Pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the world, remains
poorly understood. This makes it necessary to create animal models for studying AMD pathogenesis and to design new
therapeutic approaches. Here we showed that retinopathy in OXYS rats is similar to human AMD according to clinical
signs, morphology, and vascular endothelium growth factor (VEGF) and pigment epithelium-derived factor (PEDF)
genes expression. Clinical signs of retinopathy OXYS rats manifest by the age 3 months against the background of
significantly reduced expression level of VEGF and PEDF genes due to the decline of the amount of retinal pigment
epithelium (RPE) cells and alteration of choroidal microcirculation. The disruption in OXYS rats’ retina starts at the
age of 20 days and appears as reduce the area of RPE cells but does not affect their ultrastructure. Ultrastructural
pathological alterations of RPE as well as develop forms of retinopathy are observed in OXYS rats from age 12 months
and manifested as excessive accumulation of lipofuscin in RPE regions adjacent to the rod cells, whirling extentions of
the basement membrane into the cytoplasm. These data suggest that primary cellular degenerative alterations in the
RPE cells secondarily lead to choriocapillaris atrophy and results in complete loss of photoreceptor cells in the OXYS
rats’ retina by the age of 24 months. 
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gene expression launches angiogenesis and is a 
sufficient condition for CNV development [12,13]. New 
vessels cause edema, hemorrhages, and exudates due to 
the ability of VEGF to increase vascular permeability 
[8,9]. Application of anti-VEGF agents showed con-
vincing results in studies aimed at delaying CNV 
development in human subjects [14]. Pigment epithel-
ium-derived factor (PEDF), the most potent inhibitor of 
angiogenesis [15], serves as an antagonist of VEGF and 
the balance of these two factors regulates angiogenesis 
in retina [16,17]. It is known that a decreased level of 
PEDF in retina is associated with several proliferative 
diseases of the eye [13,18] and it may be an etiologic 
factor of AMD and be involved in switching from the 
dry to wet form. Additionally, it has been shown that 
VEGF and PEDF cross-regulate each other [19]. There 
are data about association of late stage of AMD with 
some genes, including CD36, which seems to play an 
important role in maintaining chorioretinal homeostasis 
[20]. But little is known about the involvement of 
VEGF and PEDF in formation of dry form of AMD due 
to difficulty of investigation this stage in respect to 
people. 
 
Animal models are a useful tool for studying etiology 
and pathogenesis of the disease and to test new 
therapeutic approaches and estimate their efficacy. 
There is mounting evidence that senescence-accelerated 
OXYS rats may be a suitable model of AMD [21-23]. 
According to funduscopy, signs of retinopathy, which in 
their clinical manifestations similar to those observed in 
human AMD, develop in OXYS rats to the age of 4 -5 
months. Exploration of retinal function by electroretino-
graphy had indicated reducing level of b-wave of 
scotopic electroretinogram in OXYS rats which 
progressed to complete loss of photoreceptors by 24 
months [23]. Histological study showed that choroid 
vessels, pigmented epithelium, and radial glia are most 
vulnerable to injury in the OXYS rat’s retina [22,24], 
but molecular mechanisms of retinopathy development 
in OXYS rats were not investigated as well as the 
dynamics of the clinical manifestations of disease. The 
aims of this study were to explore age-related charac-
teristics of retinopathy in OXYS rats and to identify 
distinct stages in its development based on structural 
analysis of retina and expression of VEGF and PEDF. 
 
RESULTS 
 
Ophthalmoscopy examination 
 
Retinas from 20 day-aged OXYS rats did not revealed 
the presence of any pathological signs. The first AMD-
like alterations in the fundus of the eye were found in 
22% of the OXYS rats when they reached the age of   
1.5 months (Figure 1). Alterations manifested itself as 
distorted reflectance of the fundus, swelling of the 
retina, the emergence of distinct foci of ischemia, and 
the signs of atrophy of choriocapillaris and RPE.  
 
Up to the age of 3-4 months, the morbidity had already 
reached 100% when OXYS rats exhibited the prevalent 
1st stage of the disease: drusen with signs of atrophy of 
RPE and partial loss of choriocapillaris, whereas the 
major blood vessels of choroid remained unchanged. In 
some animals, we observed detachment of pigment 
epithelium in the form of dome elevation in the 
posterior pole of the eye. Four to five percent of the 
animals at this age have features of the 2nd stage: large 
soft drusen, edema in the central zone, enlargement of 
the zone, exudative detachment of pigmented and 
neuroepithelium of the retina. The proportion of animals 
with this stage of the disease increased with age (Figure 
1), and by the age of 12 months, it reached 31%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Up to the age of 12 months, clinical symptoms of 
retinopathy worsened. The third stage was registered in 
3% of animals at 9 months, but at 12 months, it was 
apparent in 44% of the animals and was characterized 
by severe irreversible changes. The distinctive signs of 
this stage are hemorrhagic detachment of retina, dotted 
bleeding in retina, and new blood vessel formation and 
cicatrization. Importantly, neovascularization did not 
Figure 1. Distribution of the stages of development of
retinopathy in eyes of OXYS rats. 0 – 3 – corresponding
stage of the retinopathy according to Age‐Related Eye Disease
Study  grade  protocol  (http://eyephoto.ophth.wisc.edu).  790
animals were examined in total. 
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normally happens in people. By the age of 24 months, 
the changes were irreversible in nearly all animals. In 
contrast, first alteration in Wistar retina started to 
develop by the age of 24 months and could not be 
strictly classified as signs of AMD. 
 
Histological analysis and electron microscopy 
 
Light- and electron microscopy did not relive signi-
ficant differences in structure of retina of OXYS and 
Wistar rats at 20 days and 3 months. The RPE layer has 
one line of cells with normal localized nucleus, 
endoplasmic reticulum, ribosome and mitochondria 
(Figure 2). On the Figure 2 endothelial cells, which 
formed the wall of choriocapillaries, cavity of chorio-
capillaries and erythrocyte in it are good visible. But 
already at the age of 20 days, along with normally 
functioning choriocapillaries, we observed appearance 
choriocapillaries with stasis of blood cells. (Quantity 
analysis of choroid vessels and RPE cells see below).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Towards the 12 months of age, destructive changes in 
OXYS rat’s retina progressed and affect RPE/ 
Bruch’s/choriocapillaris complex in contrast to Wistar 
rats (Figure 3a) with small anomaly in Bruch’s   
membrane ultrastructure and open choriocapillaries. 
Main ultra-structural alterations are revealed in the cell 
apical part. First of all, this is the absence of a 
continuous layer     of electron-dense inclusions as well 
as practically completes absence of phagosomes – 
debris of the photoreceptor outer segments 
phagocytized by pigment epithelium, whirling 
extensions of the basement membrane into the 
cytoplasm (Figure 3b). Underlying these areas was 
pronounced thickening of Bruch’s membrane with 
disturbance of collagen and elastin layers. The 
choriocapillaris was found to have severe endothelial 
degeneration and transformation to fibrous tissue in the 
most severely affected regions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Outer retina of Wistar (a) and OXYS (b) rats at the
age of 3 months. PRL – photoreceptors, RPE – retinal pigment
epithelial  cell,  N  –  RPE  nucleus,  m  –  mitochondrion,  Ph  –
phagosome,  Lip  –  lipofuscin  material,  BM  –  Bruch’s 
membrane, Endo – endothelial cell, RBC – red blood cell. 
 
 
Figure 3. Outer retina of Wistar (a) and OXYS (b) rats at the
age  of  12  months.  Arrows  show  thickening  of  Brunch`
membrane.  RPE  –  retinal  pigment  epithelial  cell,  N  –  RPE
nucleus, m – mitochondrion, BM – Bruch’s membrane, ChC –
choriocapillaris complex, RBC – red blood cell. 
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In the retina of 24 months-aged OXYS rats, there is 
almost complete fibrosis of choroid and destruction of 
endothelium and, as a result, obliteration of cavity of 
choriocapillaries. Ultrastructure analysis of OXYS eyes 
from 24-month-old animals shown, that area of 
degenerating retina is shown from the inner nuclear 
layer to retinal pigment epithelium/Bruch’s/ chorio-
capillaris complex (Figure 4b). Outer nuclear layer and 
the photoreceptors are disorganized and fragmented. 
Changes of the RPE included significantly increased 
number of lipofuscin granules, atrophy of some RPE 
cells and vascularization (Figure 4a). Really, as the 
photo-receptor cells degenerated and the outer nuclear       
layer  and  photoreceptor  cell  layers  disappeared,            
vessels migrated toward the RPE (arrow on Figure 4a). 
Thickening of Brunch` membrane with disturbance of 
collagen and elastin layers were seen in all eyes (Figure 
5a). Also there is almost complete fibrosis of choroid 
and destruction of endothelium and, as a result, oblitera-
tion of cavity of choriocapillaris.  
 
Ultrastructure of Wistar retina had some changes that 
typical for aging, but it was not so dramatic pathology 
(Figure 5) as in OXYS rats. We can see all outer retina 
layers. It is also increased amount of lipofuscin 
granules. Cavity of most choriocapillaries decreased, 
but vessels are functionally active, as it visible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  4.  (a)  Ultrastructure  of  pigment  epithelium  of  25‐
months‐old  OXYS  rat.  Selected  area  is  shown  under  high
magnification.  Lip  –  lipofuscin  material,  N  –  retinal  pigment
epithelial cell nucleus. (b) Region of pigment epithelium of 25‐
months‐old OXYS rat. Retina injure was estimated as 3 units. INL
–  inner  nuclear  layer,  where  the  body  and  nucleus  of
interneurones is lied; OPL – outer plexiform layer – where axon
of photoreceptor and dendrite of interneurone are in contact;
ONL – outer nuclear layer, body and nucleus of photoreceptors;
PRL  –  photoreceptors,  RPE  –  retinal  pigment  epithelial  cell.
Arrow shown the blood vessel. 
 
Figure 5. Ultrastructure of outer retina of Wistar rat at
the age of 25 months. PRL – photoreceptors,    RPE – retinal
pigment  epithelial  cell,  N  –  RPE  nucleus,  Lip  –  lipo‐fuscin
material,  BM  –  Bruch’s  membrane,  Endo  –  endothelial  cell,
RBC – red blood cell. 
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that the average area of RPE cell was affected both by 
age (F4.414= 15.8, p<0.000) and by genotype (F1.39=73.4, 
p<0.000) and there was also a significant interaction 
between these two factors (F4.414=3.7, p<0.007). 
Overall, we observed well-pronounced growth with age 
the average area of RPE cells in both OXYS and Wistar 
rats from 20 days to 17 months of age (1.4- and 1.6-fold 
respectively, p<0.000). By the age of 24 months, the 
area extent of RPE cells decreased slightly compared to 
17-month-old animals, but the decline was significant 
only in the Wistar rats (p<0.00004), while in the OXYS 
strain, we detected only a tendency for lowering 
(p<0.056) as shown on Figure 6a. 
 
Pairwise comparisons within the strains revealed 
reduction of average area of RPE cell already in                 
20-day-old OXYS rats by 22% compared to Wistar       
rats (p<0.000).   At  ages  3,  6,  17  and 24  months,  the 
differences remained and this parameter was lower in 
OXYS rats by 15% (p<0.023), 33% (p<0.000), 28% 
(p<0.001) and 16% (p<0.026), respectively. 
 
ANOVA analysis  of  morphometry  data  revealed  age- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
related increasing of the specific area of choriocapillaris 
with stasis and thrombosis (F4.68= 22.4, p<0.000), which 
was observed in rats of both strains. In addition, its 
quantity was affected by genotype (F1.68=56.7, 
p<0.000), and since the age of 20 days, specific area of 
vessels with signs of partial occlusion of retinal vessels 
was greater in OXYS rats compared to the age-matched 
Wistar controls (Figure 7b). There was also a significant 
interaction between these two factors (F4.68=4.8, 
p<0.002).  As shown in the Figure 6b, in the Wistar 
retina, the number of vessels with thrombosis and stasis 
remained unchanged between 20 days and 17 months of 
age. Only at age 24 months the percentage of 
choriocapillaris with signs of abnormality became 5.6-
fold greater than that in the 20-day-old animals. 
 
OXYS rats exhibited a relatively rapid expansion of 
specific area of choriocapillaris with stasis and 
thrombosis already by age 6 months. Up to the age of 
24 months, these pathological changes progressed, but 
at a slower rate. As a result, at ages 3, 6, and 24 months, 
this parameter in the OXYS retina was 2.6-,  3.6-, and 
4-fold higher compared to 20-day-old OXYS rats 
(p<0.006, p<0.0002, p<0.0001, respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Age‐related changes of the average area of RPE cells (a) and specific area of vessels with
stasis and thrombosis (b) in the retinas’ sections of OXYS and Wistar rats. *interstrain differences;
^differences in comparison with previous age; p<0.05. Data presented as mean ± S.E.M. 
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Gene Expression 
 
Expression of VEGF gene was affected both by age 
(F4.39= 18.3, p<0.000) and by genotype (F1.39=10.0, 
p<0.003) and there was also a significant interaction 
between these two factors (F4.39=3.3, p<0.020). The 
same was observed for expression of PEDF gene: age - 
F4.39=46.9; p<0.000; genotype - F1.39=4.5; p<0.040. 
Factors also interacted with each other (F4.39=3.1; 
p<0.026), which is probably due to the differences in 
age-dependent changes of retinal VEGF and PEDF 
expression between Wistar and OXYS strains. Post hoc 
analysis revealed that the maximum level of genes 
mRNA was in the retina at the age of 20 days (Figure 6) 
and had not difference between strains. Expression of 
VEGF and PEDF genes decreased 10-fold (p<0.000) 
and 5-fold (p<0.001) respectively between 20 days and 
24 months of age in both Wistar and OXYS rats. At the 
same time, in OXYS rats, the reduction progressed 
more rapidly than in Wistar (Figure 7). 
 
At the age of 20 days, there was no difference
 between 
Wistar and OXYS rats in terms of expression of VEGF 
and PEDF. But already at the age of 3 months, VEGF 
expression (Figure 7a) in OXYS rats was almost  10-
fold lower (F1.8=21.9, p<0.002) compared to 20-day-old 
animals and to age-matched Wistar rats (F1.8=21.7, 
p<0.002) and PEDF expression (Figure 7b) decreased 
three-fold (p<0.0001) from age 20 days to 3 months and 
was about two-fold lower (F1.8=7.29; p<0.027) 
compared to the age-matched Wistar animals (F1.8=7.29; 
p<0.027).  Expression of  both genes in  OXYS  rats  re- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
mained without significant changes throughout the rest 
of the observation period.  
 
VEGF expression at the age of 24 months was 4- 
(p<0.002) and 2.6-fold higher (p<0.008) than in 12 and 
17-month-old Wistar rats respectively, and it reached 
half of the expression level at the age of 20 days 
(p<0.0003). By the age of 24 months, PEDF expression 
increased by 2.4-fold (p<0.013) compared to 17-month-
old Wistar rats (Figure 7). 
 
DISCUSSION 
 
Based on the results of the ophthalmoscopic exam-
ination we can define two periods for development 
retinopathy in OXYS rats. The first period is 
manifestation of early disease signs from 1.5 to 3 
months of age. The second period from 12 to 14 months 
corresponds to advanced stage of retinopathy. Our 
morphological investigation confirmed that the same 
retinal structure is involved in pathological processes in 
OXYS rats as in humans AMD [25,26]. Primary cellular 
degenerative alterations have been observed first in the 
RPE cells of OXYS rats, which secondarily lead to 
damage in the choriocapillaries and photoreceptor cells. 
 
It is extremely important that we found changes in the 
OXYS retina already at the age of 20 days, when any 
obvious clinical signs are absent. Fist alteration of RPE 
cells in the retina of OXYS rats begin at the age of 20 
days, are aggravated to 3-6 months by disturbances of 
microcirculation, and at this age correspond  to           
Figure 7. Messenger RNA (mRNA) expression of (a) vascular endothelium growth factor (VEGF) and (b) pigment
epithelium‐derived factor (PEDF) in retina determined by real‐time polymerase chain reaction (PCR), N=5. Data
presented as mean ± S.E.M. *interstrain differences; ^differences in comparison with previous age; p<0.05. 
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maintaining the structure and function of the retina, the 
early alteration of RPE cells may be a key initiating 
factor for retinopathy development in OXYS rats and a 
cause of all subsequent pathological changes. Clinical 
and experimental data suggest that normal aging 
processes can lead to structural and blood flow changes 
that  can  predispose  an  individual  to  AMD,  although 
advanced age does not inevitably cause AMD [27,28]. 
Thus our investigation has shown that particularly age-
related changes of retinal ultrastructure in Wistar and 
OXYS rats are non-specific, generally speaking, but the 
age of onset and rate of retinopathy development differ 
sharply between these strains. At the same time in 
support of our previous reports [24], the present results 
indicate evidence of impaired of phagocytic function of 
RPE in the adult 12 months-old OXYS rats. One of the 
main functions of the  RPE  is the  phagocytosis of shed 
photoreceptor outer segments. Photoreceptors are 
exposed to intense levels of light, thus leading to 
accumulation of photo-damaged proteins and lipids [1]. 
As opposed to Wistar rats in OXYS rats lipofuscin 
granules are accumulated in the base of the RPE cell 
offshoots and fill in the space between rod cells, thus 
contributing to the development of further disturbances in 
the visual cycle functioning. Practically complete absen-
ce of phagosomes also points to disturbances in funct-
ioning of photoreceptor membranes in OXYS rats’ retina. 
It is known that experimental destruction of RPE cause 
atrophy of choriocapillaries in rat’s retina [4] and we 
observed the same phenomenon in the OXYS retina: 
with increasing age, the combined atrophy of RPE cells 
and choriocapillaris. The relationship between RPE and 
capillary endothelium can be mediated by VEGF 
signaling [10]. 
 
We can hypothesize that the accelerated decrease of 
VEGF and PEDF genes expression at the mRNA level 
in OXYS rats is due to early RPE dysfunction because 
both of these genes are primarily expressed in RPE 
cells. Also recently it was shown [29] that loss of 
polarity of RPE cells in AMD may results in alteration 
of PEDF, VEGF expression and lead to marked loss of 
neurotrophic and vascular support for the retina 
potentially leading to photoreceptor loss and blindness. 
This notion is supported by our data from 
morphological and ultrastructure analysis and exam-
ination of VEGF and PEDF genes expression. We found 
that expression of those genes decreased with age in 
both rat strains, with the maximum around 20 days of 
age. In this case, our data confirms the results of Steinle 
and coworkers [27] who observed a decrease of VEGF 
and PEDF gene expression during normal aging of 
retina.  
We suppose that the age-related decrease of VEGF gene 
expression is premised for development signs of early 
AMD. Indeed, we found that the early stage of 
retinopathy in OXYS rats formed simultaneously with 
the significantly decreased expression level of VEGF 
and PEDF genes compared to control rats. That 
alteration of genes expression may disrupt physiologic 
feedback between RPE and choriocapillaries and lead to 
the subsequent atrophy of blood vessels, development 
of hypoxia in outer retina. In literature, there are many 
reports that support the existence of such a mechanism 
that provides fine-tuning of choriocapillaries for the 
necessary nutrient supply to the outer retina [8,10]. 
Most sensitive to hypoxia multifunctional RPE cells 
maintain complex structure of the whole retina [1] and 
its dysfunction is critical for development of retino-
pathy. There is a vicious circle: retinal ischemia results 
in damage to the pigment epithelium, which explains 
the reduced level of VEGF and PEDF gene expression, 
which in turn leads to the choriocapillaries atrophy, 
exacerbating ischemia, thereby contributing to the 
development of retinopathy. 
 
We found an increase of VEGF and PEDF mRNA 
expression at age 24 months in Wistar rats, which is in 
good agreement with the results of Steinle [27]. VEGF 
gene expression gradually increased starting from 12 
months of age, while the expression of PEDF from 17 
months of age in these rats. Early signs of retinopathy 
became manifested in 24 month-old Wistar rats and 
such an upregulation of the expression of certain genes 
might be a compensatory reaction to the age-related 
changes in retina. It is known that VEGF and PEDF 
regulate expression of each other [19,30,31]. Thus, we 
can assume that by the age of 24 months, there were 
hypoxic conditions present in the Wistar retina due to 
age-related decrease of VEGF and it caused the 
upregulation of VEGF gene expression. On the other 
hand, VEGF promotes expression of PEDF gene and 
this may serve as a physiological regulatory mechanism 
that probably prevents switching from the dry to wet 
form and CNV. Those age-related changes may form 
the basis for AMD development.  
 
It is interesting that at age 17 months, expression of 
VEGF and PEDF genes in the OXYS retina increased, 
same as in Wistar rats, but subsequently, the expression 
of those genes in OXYS rats declined to a rather low 
level. We propose that in OXYS rats, the compensatory 
mechanism that responds to retina damage is either 
suppressed or disrupted due to the impaired function of 
RPE cells. The decreased average area of RPE cells in 
OXYS rats in comparison with Wistar did not allow for 
an adequate compensatory response, and it led to almost 
complete degeneration of retina in OXYS rats by age 24 
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was formed at a previous period of retinopathy in 
OXYS rats.  
 
Advanced AMD is linked with increased VEGF gene 
expression, especially during development of CNV [11]. 
We did not find an increasing mRNA level of VEGF at 
age 12 months or older in OXYS rats (age of formation 
of developed retinopathy) compared to Wistar rats. 
Nevertheless, it increased in 17 month-old OXYS rats 
compared to its own baseline and, therefore, this 
observation is in good agreement with experimental 
data in humans. It might be supposed that the observed 
VEGF level is increased locally because the amount of 
RPE cells is decreased according to our histological 
investigation. To clarify this question, it would be 
necessary to perform an immunohistochemical study of 
the OXYS retina. Bhrutto and colleagues [18] have 
shown that the cause of the increased VEGF level is 
immune cells, which migrate to the retina.  
 
The most important question now is what determines 
the switching between dry and wet form of AMD. 
DanHong Zhu et al. [32] found that bone morpho-
genetic protein-4 (BMP4) is differentially expressed in 
atrophic and neovascular AMD. Early they shown that 
BMP4 can induce RPE senescence in vitro [33], and 
that RPE chronically exposed to sublethal doses of 
oxidative stress can increase their BMP4 expression and 
exhibit a senescent phenotype, thus supporting the 
contention that BMP4 mediates oxidative stress-induced 
RPE senescence. The same situation may be in OXYS 
rats due to mitochondria dysfunction [23]. 
 
The causes of early alteration of RPE cells in OXYS 
rats are not yet clear. In the eye, the retinal pigment 
epithelium (RPE) is exposed to a highly oxidative 
environment, partly due to elevated oxygen partial 
pressure from the choriocapillaris and to digestion of 
polyunsaturated fatty acids from photoreceptor outer 
segments [34]. There is strong evidence for mitochon-
drial dysfunction being involved in AMD [35,36] and 
oxidative stress is the main injury mechanism. Thus, it 
is logical to suppose that the early decline of RPE in the 
retina of OXYS rats may be associated with genetic 
predisposition to mitochondrial dysfunction. This 
hypothesis is supported by one study which demon-
strated significant destruction of mitochondria in RPE 
of OXYS rats [23]. Nonetheless, we had shown 
previously that there were no signs of energy deficiency 
in the brain of 3-months-old OXYS rats. Additionally, 
already at age 20 days, there are signs of adaptation to 
hypoxia in the brain without energy deficiency, for 
example, an increased amount of phosphocreatine in 
OXYS rats as compared to Wistar rats [37]. Retina 
develops as a part of the brain and it seems logical that 
mitochondrial dysfunction must be a consequence of 
some pathology in early ontogenesis. Be that as it may, 
clarification of this question would necessitate further 
studies of mitochondrial function in retinal tissue.  
 
In the present and in a previous report [24] we observed 
redistribution of lipofuscin granules in RPE cells in 11- 
to 13-month-old OXYS rats. These granules are known 
to have a strong phototoxic potential mediated by light-
dependent ROS generation and they could be a reason 
for further RPE degeneration. The observed pattern of 
redistribution of lipofuscin granules confirmed that the 
cellular functions of RPE in OXYS rats are either 
impaired or completely disrupted. 
 
The set of clinical, morphological and molecular 
features of retinal degeneration in OXYS rats suggests 
that these animals are adequate model of AMD. This 
animal model could be used for studying pathogenesis 
of early stages of the disease including preclinical 
changes and to test therapeutic action of drugs. In this 
view, our previous experiments with OXYS rats 
supported therapeutic benefits of bilberry (Vaccinium 
myrtillus) extract [38]. Investigation carried out on 
OXYS rats, at first time had demonstrated unique 
therapeutic potential of the novel mitochondria-targeted 
antioxidant SkQ1, (10-(6'-plastoquinonyl) decyltri-
phenylphosphonium) for AMD treatment. We showed 
recently that addition of SkQ1 to the food or in the form 
of droplets completely is able to not only prevent 
retinopathy but also to reduce the severity of already 
developed pathological changes of retina in OXYS rats 
[23]. 
 
METHODS 
 
Animals.  The OXYS rat strain was developed at the 
Institute of Cytology and Genetics from Wistar stock by 
selection on the basis of susceptibility to cataractogenic 
effects of a galactose-rich diet and by inbreeding of 
highly susceptible rats as described earlier [39,40] and 
registered in the Rat Genome Database [41]. Today we 
have the 94nd generation of OXYS rats with spontan-
eously developing cataract and accelerated-senescence 
syndrome inherited in a linked manner. Cataract still 
serves as the key parameter for maintaining the 
phenotype of OXYS strain whereas the other signs of 
accelerated senescence, including retinopathy, appeared 
as concomitant.  
 
Male OXYS and male Wistar (as controls) rats were 
born and reared at the Center for Genetic Resources of 
Laboratory Animals of Institute of Cytology and 
Genetics SB RAS (Novosibirsk, Russia). At the age of 4 
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and housed in groups of five animals per cage 
(57×36×20 cm) and kept under standard laboratory 
conditions (at 22±2
oC, 60% relative humidity, and 
natural light), provided with a standard rodent feed, PK-
120-1, Ltd. (Laboratorsnab, Russia), and given water ad 
libitum. 
 
Ophthalmoscopic examination. Ophthalmoscopic exam-
ination of OXYS and Wistar rats was carried out using a 
Beta direct ophthalmoscope (Germany) equipped with a 
slit lamp, after dilatation with 1% tropicamide. 
Assessment of stages of retinopathy was carried out 
according to Age-Related Eye Disease Study (AREDS) 
grade protocol (http://eyephoto.ophth.wisc.edu). In 
total, we examined 790 animals between 20 days and 24 
months of age. 
 
Histological analysis and electron microscopy. A total 
of 42 OXYS and 37 age-matched Wistar rats were used 
for histological and morphometry studies. Animals were 
examined at the age of 20 days, 3, 6, 12 and 24 months 
(6 – 10 per group). For studies of the main parameters, 
we selected retinas on the basis of fundoscopy findings 
in OXYS rats. Morphological analysis was performed 
as described earlier [21]. The posterior wall of the eye 
was collected, fixed in 2.5% glutaraldehyde, postfixed 
in 2% OsO4, dehydrated in ascending concentrations of 
alcohol and in acetone, and embedded in epon-812. 
Semi-thin sections were sliced on an LKB-4 ultratome 
and stained with 0.1%   toluidine blue. Counting was 
carried out on photo-graphs covering section regions 
from 50 to 250 mkm.  RPE cells’ area and specific area 
of choroid vessels were measured using quantitative 
analyses of the images were performed using 
Axiovision software (Zeiss, Thornwood, NY). Estima-
tion was performed by examination 50 fields of view 
for each animal. 
 
Ultrastructural study was performed on OXYS and 
Wistar rats at the age of 3, 12 and 24 months.  Per 5 
animals were in each group and in each of eye 3 areas 
were analyzed. Material for electron microscopy was 
fixed for 2 h at 4°C in 3% glutaraldehyde solution in 
buffer, pH 7.4. Then the material was additionally fixed 
with 1 % osmium tetroxide solution for 1.5  h and 
dehydrated in solutions of increasing alcohol concen-
trations (70% ethanol saturated with uranyl acetate). 
The material was embedded in Epon-812 epoxide resin. 
Serial ultrathin sections were prepared on a Leica 
Ultracut ultramicrotome (Leica, Austria) and stained 
with lead according to Reynolds [42]. The preparations 
were examined and photographed in a HU-1lB electron 
microscope (Hitachi, Japan).  
RNA extraction and real-time PCR. Analysis of steady-
state mRNA expression of VEGF in the retina of OXYS 
rats was completed at 20 days, 3, 12, 17, and 24 months 
of age (Wistar strain as control, 5 animals in each age 
group). At the appropriate age, rats were decapitated 
and eyes were removed. Retina for gene expression 
analysis was separated from the other tissue, placed into 
tubes for RNA isolation and frozen in liquid nitrogen. 
All specimens were stored at -70ºC prior to the analysis.  
 
Total cell RNA was isolated from rat retina by TRI-
Reagent (Ambion) according to the manufacturer`s 
instructions. The amount of isolated RNA was 
evaluated by means of electrophoresis of 1 μl of each 
RNA sample in 1.5% agarose gel. RNA content was 
determined in each sample using spectrophotometry at 
260 nm and also by absorbance ratios 260/280 nm and 
260/320 nm. RNA was stored at –70°C. Contamin- 
ating  genomic  DNA  was  removed  by  treatment        
with DNase I (Promega, USA) according to the manu-
facturer`s instructions and then by repeated RNA 
extraction with the phenol–chloroform mixture and pure 
chloroform followed by precipitation with propanol. 
Reverse transcription was performed using M-MLV 
Reverse Transcriptase (Promega, USA) following the 
manufacturer’s protocol. For subsequent PCR, we used 
of 0.25-1.0 μl of the resulting cDNA mixture.  
 
Aliquots (4 μl) from all cDNA samples were mixed and 
the “average” solution was used for preparation of 
calibration curves, which were used for determination 
of relative cDNA level for genes of interest and a 
reference gene in experimental samples.  
 
Age-related changes of vegf and pedf  gene  expres-    
sion were investigated using iCycler iQ4 real-time       
PCR detection system (Bio-Rad Laboratories, USA) 
and  SYBR  Green  I  dye  (Molecular  Probes,  USA).           
The housekeeping gene Rpl30 (encoding large 
ribosomal subunit protein 30) was used as a refer-       
ence  gene.  The  following  primers  were  used:                    
Rpl30 5′_ATGGTGGCTGCAAAGAAGAC_3′  and         
5′_CAAAGCTGGACAGTTGTTGG_3′; vegf 
5′_CTGGCTTTACTGCTGTACCTCCACC_3′ and 
5′_GGCACACAGGACGGCTTGAA_3′; pedf 
5′_GATTGCCCAGCTGCCTTTGACA_3′        a n d  
5′_GGGACAGTCAGCACAGCTTGGATAG_3′. 
 
The reaction mixture (final volume of 25 μl) contained 
the standard PCR buffer (67 mM Tris-HCl, pH 8.9, 16 
mM (NH4)2SO4, 0.01% Tween 20, and 10 mM β-
mercaptoethanol), MgCl2 (3 mM for vegf, 1.5 mM for 
RPL30, 3 mM for pedf), 0.2 mM dNTPs, SYBRGreen I 
(1: 20,000 dilution), 150 nM primers, and 0.8 U of Taq 
polymerase (Institute of Cytology and Genetics, 
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conditions: heating at 95°C for 3 min, 40 cycles: 
denaturation at 95°C for 20 sec, annealing 20 sec, 
elongation at 72°C 30 sec; data collection was based on 
fluorescence for Rpl30 at 84°C for 30 sec, data 
collection by fluorescence for vegf and pedf genes at 
87°C for 10 sec. After completion of PCR, the melting 
curves for specificity control were recorded. In each 
experiment, samples of investigated cDNA were mixed 
with primers for a gene of interest (four repeats per 
cDNA sample) in one microtube plate; similar samples 
were mixed with primers for the reference gene (also 
four repeats). “Standard” cDNA was diluted from 1:2 to 
1:64 with the same primers (2-3 repeats). For each 
cDNA sample, PCR was repeated at least twice. To 
confirm amplicon size and reaction specificity, PAGE 
electrophoresis was performed with DNA molecular 
weight markers.  
 
The initial level of expression of investigated cDNA 
was determined by standard calibration curves (versus 
“standard” cDNA) and this value was obtained for each 
gene of interest and normalized according to the amount 
of the reference gene cDNA [43]. 
 
Statistical analysis.  The data were analyzed using 
repeated measures ANOVA and nonparametric tests 
with the statistical package Statistica 6.0. Two-way 
ANOVA was used to evaluate the differences between 
OXYS and Wistar rats across ages (age x genotype). A 
Newman–Keuls post hoc test was applied to significant 
main effects and interactions in order to estimate the 
differences between particular sets of means. One-way 
ANOVA was used for individual group comparisons. 
Data are represented as mean ± S.E.M. Results were 
considered statistically significant if p value was less 
than 0.05. 
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